Is­rael sues Te­va over block­buster MS drug, seek­ing $100M in roy­al­ty pay — re­port

As Te­va is fac­ing opi­oid lit­i­ga­tion and po­ten­tial set­tle­ments in the US, it is now fac­ing more lit­i­ga­tion on the oth­er side of the world — on its own turf.

First re­port­ed by Globes, the State of Is­rael filed a law­suit Wednes­day in a dis­trict court seek­ing a $100 mil­lion judg­ment against Te­va, with the state claim­ing that the com­pa­ny vi­o­lat­ed the state’s rights to cer­tain re­search by not pay­ing roy­al­ties for Co­pax­one, a block­buster mul­ti­ple scle­ro­sis treat­ment that Te­va re­tains mar­ket­ing rights for.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER